SI2590973T1 - Soli solifenacina - Google Patents
Soli solifenacinaInfo
- Publication number
- SI2590973T1 SI2590973T1 SI201130976A SI201130976A SI2590973T1 SI 2590973 T1 SI2590973 T1 SI 2590973T1 SI 201130976 A SI201130976 A SI 201130976A SI 201130976 A SI201130976 A SI 201130976A SI 2590973 T1 SI2590973 T1 SI 2590973T1
- Authority
- SI
- Slovenia
- Prior art keywords
- solifenacin
- salts
- solifenacin salts
- Prior art date
Links
- FBOUYBDGKBSUES-VXKWHMMOSA-N solifenacin Chemical class C1([C@H]2C3=CC=CC=C3CCN2C(O[C@@H]2C3CCN(CC3)C2)=O)=CC=CC=C1 FBOUYBDGKBSUES-VXKWHMMOSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10168415 | 2010-07-05 | ||
US201161472807P | 2011-04-07 | 2011-04-07 | |
PCT/EP2011/061314 WO2012004264A1 (en) | 2010-07-05 | 2011-07-05 | Solifenacin salts |
EP11728902.5A EP2590973B1 (en) | 2010-07-05 | 2011-07-05 | Solifenacin salts |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2590973T1 true SI2590973T1 (sl) | 2017-01-31 |
Family
ID=44627779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201130976A SI2590973T1 (sl) | 2010-07-05 | 2011-07-05 | Soli solifenacina |
Country Status (7)
Country | Link |
---|---|
US (1) | US8765785B2 (sl) |
EP (1) | EP2590973B1 (sl) |
JP (1) | JP5826262B2 (sl) |
CA (1) | CA2804107A1 (sl) |
ES (1) | ES2596293T3 (sl) |
SI (1) | SI2590973T1 (sl) |
WO (1) | WO2012004264A1 (sl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2778167A1 (en) * | 2013-03-11 | 2014-09-17 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Stable pharmaceutical composition comprising amorphous solifenacin or its pharmaceutically acceptable salt |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO2005012I1 (no) | 1994-12-28 | 2005-06-06 | Debio Rech Pharma Sa | Triptorelin og farmasoytisk akseptable salter derav |
EP1714965A4 (en) | 2004-02-09 | 2007-12-19 | Astellas Pharma Inc | COMPOSITION CONTAINING SOLIFENACINE SUCCINATE |
WO2005087231A1 (ja) | 2004-03-16 | 2005-09-22 | Astellas Pharma Inc. | ソリフェナシン含有組成物 |
CA2561167C (en) | 2004-03-25 | 2012-09-11 | Astellas Pharma Inc. | Composition of solifenacin or salt thereof for use in solid formulation |
CA2591761A1 (en) | 2004-12-27 | 2006-07-06 | Astellas Pharma Inc. | Stable particulate pharmaceutical composition of solifenacin or salt thereof |
WO2008011462A2 (en) | 2006-07-19 | 2008-01-24 | Dr. Reddy's Laboratories Ltd. | Process for preparing solifenacin and its salts |
CZ300692B6 (cs) | 2006-12-22 | 2009-07-15 | Zentiva, A. S. | Zpusob prípravy solifenacinu |
US20100298371A1 (en) | 2007-12-04 | 2010-11-25 | Mayank Ghanshyambhai Dave | Process for preparing chemically and chirally pure solifenacin base and its salts |
WO2009139002A2 (en) | 2008-05-12 | 2009-11-19 | Msn Laboratories Limited | An improved process for the preparation of solifenacin and its pharmaceutically acceptable salts thereof |
EP3067353B1 (en) | 2008-07-29 | 2017-11-22 | KRKA, D.D., Novo Mesto | A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms |
-
2011
- 2011-07-05 SI SI201130976A patent/SI2590973T1/sl unknown
- 2011-07-05 EP EP11728902.5A patent/EP2590973B1/en not_active Not-in-force
- 2011-07-05 ES ES11728902.5T patent/ES2596293T3/es active Active
- 2011-07-05 JP JP2013517361A patent/JP5826262B2/ja not_active Expired - Fee Related
- 2011-07-05 WO PCT/EP2011/061314 patent/WO2012004264A1/en active Application Filing
- 2011-07-05 CA CA2804107A patent/CA2804107A1/en not_active Abandoned
- 2011-07-05 US US13/805,828 patent/US8765785B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2590973B1 (en) | 2016-08-31 |
JP2013530201A (ja) | 2013-07-25 |
US20130203804A1 (en) | 2013-08-08 |
JP5826262B2 (ja) | 2015-12-02 |
US8765785B2 (en) | 2014-07-01 |
WO2012004264A1 (en) | 2012-01-12 |
CA2804107A1 (en) | 2012-01-12 |
ES2596293T3 (es) | 2017-01-05 |
EP2590973A1 (en) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1199840A1 (en) | Noribogaine salt ansolvates | |
HK1203196A1 (en) | Substituted benzylpyrazoles | |
IL229513A0 (en) | imidazopyridine compounds | |
EP2717377A4 (en) | DRUMS | |
EP2782184A4 (en) | BATTERY | |
IL231152B (en) | buildings for storage | |
GB201113558D0 (en) | Kraftfahrzeugkarosserie mit strukturverstarkter vorderrahmenanbindung | |
DK2786756T3 (en) | Kombinationsterapi med en topoisomeraseinhibitor | |
EP2622916A4 (en) | POSITIONING | |
EP2686897A4 (en) | BATTERY | |
GB201304499D0 (en) | Carcainium Salts | |
GB201116180D0 (en) | Kraftfahrzeug mit warnsystem | |
EP3701800C0 (en) | USE | |
ZA201402554B (en) | Rotatable joint | |
EP2725637A4 (en) | BATTERY | |
PL2609093T3 (pl) | Związek soli | |
GB201107560D0 (en) | Underwater location | |
EP2785766A4 (en) | HYDROXYPOLYAMINSALZE | |
EP2690698A4 (en) | BATTERY | |
EP2755264A4 (en) | BATTERY | |
PL2604863T3 (pl) | Sprężarka rotacyjna | |
PL2665867T3 (pl) | Tor | |
GB2484028B (en) | Power-scalable betavoltaic battery | |
PL2388095T3 (pl) | Narzędzie do frezowania | |
SI2590973T1 (sl) | Soli solifenacina |